Jean Benard
Villejuif, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: September 09, 2020
Revisiting the human polypeptide GalNAc-T1 and T13 paralogs.
Journal: Glycobiology
Published: June 30, 2016
WT1 expression is inversely correlated with MYCN amplification or expression and associated with poor survival in non-MYCN-amplified neuroblastoma.
Journal: Molecular oncology
Published: May 23, 2015
Regulation by miR181 family of the dependence receptor CDON tumor suppressive activity in neuroblastoma.
Journal: Journal of the National Cancer Institute
Published: October 15, 2014
TWIST1 is a direct transcriptional target of MYCN and MYC in neuroblastoma.
Journal: Cancer letters
Published: September 17, 2014
Revised risk estimation and treatment stratification of low- and intermediate-risk neuroblastoma patients by integrating clinical and molecular prognostic markers.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: April 07, 2014
Expression of two parental imprinted miRNAs improves the risk stratification of neuroblastoma patients.
Journal: Cancer medicine
Published: February 12, 2014
WNT5A encodes two isoforms with distinct functions in cancers.
Journal: PloS one
Published: July 10, 2013
Explicative models of cancer biology: an enlarged vision
Journal: Bulletin du cancer
Published: June 11, 2013
GALNT9 gene expression is a prognostic marker in neuroblastoma patients.
Journal: Clinical chemistry
Published: November 09, 2012
Loss of the malignant phenotype of human neuroblastoma cells by a catalytically inactive dominant-negative hTERT mutant.
Journal: Molecular cancer therapeutics
Published: August 31, 2012
Last Updated: 09/26/2026